ALYFTREK

At a glance

Key dates

1. Approval

   FDA approval date of this drug product.

   Dec 20, 2024

   1 yr 6 mo ago

2. Today

3. Patent 8354427 expires

   Listed method-of-use patent (U-4091) expiration.

   Jul 06, 2026

   in 17 d

4. Patent 8410274 expires

   Listed drug product patent expiration.

   Dec 28, 2026

   in 6 mo

5. Patent 8754224 expires

   Listed drug substance patent expiration.

   Dec 28, 2026

   in 6 mo

6. Patent 9670163 expires

   Listed drug product patent expiration.

   Dec 28, 2026

   in 6 mo

7. Patent 9670163 expires

   Listed drug product patent expiration.

   Dec 28, 2026

   in 6 mo

8. Patent 9931334 expires

   Listed drug product patent expiration.

   Dec 28, 2026

   in 6 mo

9. Patent 9931334 expires

   Listed drug product patent expiration.

   Dec 28, 2026

   in 6 mo

10. Patent 10022352 expires

    Listed drug product patent expiration.

    Apr 09, 2027

    in 10 mo

11. Patent 10239867 expires

    Listed drug substance patent expiration.

    Apr 09, 2027

    in 10 mo

12. Patent 10239867 expires

    Listed drug substance patent expiration.

    Apr 09, 2027

    in 10 mo

13. Patent 11639347 expires

    Listed drug substance patent expiration.

    Apr 09, 2027

    in 10 mo

14. Patent 11639347 expires

    Listed drug substance patent expiration.

    Apr 09, 2027

    in 10 mo

15. Patent 9974781 expires

    Listed drug product patent expiration.

    Apr 09, 2027

    in 10 mo

16. Patent 9974781 expires

    Listed drug product patent expiration.

    Apr 09, 2027

    in 10 mo

17. Patent 7645789 expires

    Listed drug substance patent expiration.

    May 01, 2027

    in 11 mo

18. Patent 8598181 expires

    Listed method-of-use patent (U-4090) expiration.

    May 01, 2027

    in 11 mo

19. Patent 8598181 expires

    Listed method-of-use patent (U-4463) expiration.

    May 01, 2027

    in 11 mo

20. Patent 8623905 expires

    Listed drug substance patent expiration.

    May 01, 2027

    in 11 mo

21. Patent 7495103 expires

    Listed drug substance patent expiration.

    May 20, 2027

    in 11 mo

22. Patent 7776905 expires

    Listed drug substance patent expiration.

    Jun 03, 2027

    in 1 yr

23. Patent 8324242 expires

    Listed method-of-use patent (U-4090) expiration.

    Aug 05, 2027

    in 1 yr 2 mo

24. Patent 8324242 expires

    Listed method-of-use patent (U-4464) expiration.

    Aug 05, 2027

    in 1 yr 2 mo

25. Patent 8415387 expires

    Listed method-of-use patent (U-4082) expiration.

    Nov 12, 2027

    in 1 yr 5 mo

26. Patent 8415387 expires

    Listed method-of-use patent (U-4463) expiration.

    Nov 12, 2027

    in 1 yr 5 mo

27. Patent 10646481 expires

    Listed drug product patent expiration.

    Aug 13, 2029

    in 3 yr 2 mo

28. Patent 11564916 expires

    Listed method-of-use patent (U-4095) expiration.

    Aug 13, 2029

    in 3 yr 2 mo

29. Patent 11564916 expires

    Listed method-of-use patent (U-4466) expiration.

    Aug 13, 2029

    in 3 yr 2 mo

30. Exclusivity ends · NCE

    New chemical entity exclusivity (5 years)

    Dec 20, 2029

    in 3 yr 7 mo

31. Patent 10081621 expires

    Listed drug product patent expiration.

    Mar 25, 2031

    in 4 yr 10 mo

32. Patent 10081621 expires

    Listed drug product patent expiration.

    Mar 25, 2031

    in 4 yr 10 mo

33. Patent 11578062 expires

    Listed drug product patent expiration.

    Mar 25, 2031

    in 4 yr 10 mo

34. Patent 11578062 expires

    Listed drug product patent expiration.

    Mar 25, 2031

    in 4 yr 10 mo

35. Patent RE50453 expires

    Listed drug substance patent expiration.

    Jul 10, 2031

    in 5 yr 2 mo

36. Exclusivity ends · ODE-526

    Orphan-drug exclusivity (7 years)

    Dec 20, 2031

    in 5 yr 7 mo

37. Patent 10047053 expires

    Listed drug substance patent expiration.

    May 17, 2032

    in 6 yr

38. Patent 8865902 expires

    Listed drug substance patent expiration.

    May 17, 2032

    in 6 yr

39. Patent 9181192 expires

    Listed drug substance patent expiration.

    May 17, 2032

    in 6 yr

40. Patent 9181192 expires

    Listed drug substance patent expiration.

    May 17, 2032

    in 6 yr

41. Patent 9512079 expires

    Listed drug substance patent expiration.

    May 17, 2032

    in 6 yr

42. Patent 9512079 expires

    Listed drug substance patent expiration.

    May 17, 2032

    in 6 yr

43. Exclusivity ends · ODE-536

    Orphan-drug exclusivity (7 years)

    Mar 27, 2033

    in 6 yr 10 mo

44. Patent 11066417 expires

    Listed drug substance patent expiration.

    Feb 14, 2039

    in 12 yr 10 mo

45. Patent 11866450 expires

    Listed method-of-use patent (U-4082) expiration.

    Feb 14, 2039

    in 12 yr 10 mo

46. Patent 11866450 expires

    Listed method-of-use patent (U-4463) expiration.

    Feb 14, 2039

    in 12 yr 10 mo

47. Patent 11873300 expires

    Listed drug substance patent expiration.

    Aug 13, 2040

    in 14 yr 4 mo

48. Patent 11873300 expires

    Listed drug substance patent expiration.

    Aug 13, 2040

    in 14 yr 4 mo

Pharmaceutical detail

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

Marketing exclusivity (3)

• NCENew chemical entity exclusivity (5 years)

  Dec 20, 2029

  in 3 yr 7 mo

• ODE-526Orphan-drug exclusivity (7 years)

  Dec 20, 2031

  in 5 yr 7 mo

• ODE-536Orphan-drug exclusivity (7 years)

  Mar 27, 2033

  in 6 yr 10 mo

Listed patents (43)